Pharma & Healthcare
Global Vaccines Administered Orally Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4298
- Pages: 110
- Figures: 144
- Views: 15
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Vaccines Administered Orally market is projected to grow from US$ 1936 million in 2024 to US$ 2746.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.
Report Covers:
This report presents an overview of global market for Vaccines Administered Orally, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccines Administered Orally, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Vaccines Administered Orally, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccines Administered Orally sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccines Administered Orally market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccines Administered Orally sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Human
Animal
Segment by Application
Public
Private
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Vaccines Administered Orally in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Vaccines Administered Orally manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines Administered Orally sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Vaccines Administered Orally market is projected to grow from US$ 1936 million in 2024 to US$ 2746.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.
Report Covers:
This report presents an overview of global market for Vaccines Administered Orally, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccines Administered Orally, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Vaccines Administered Orally, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccines Administered Orally sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccines Administered Orally market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccines Administered Orally sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Human
Animal
Segment by Application
Public
Private
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Vaccines Administered Orally in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Vaccines Administered Orally manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines Administered Orally sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Vaccines Administered Orally Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Administered Orally Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Human
1.2.3 Animal
1.3 Market by Application
1.3.1 Global Vaccines Administered Orally Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaccines Administered Orally Sales Estimates and Forecasts 2019-2030
2.2 Global Vaccines Administered Orally Revenue by Region
2.2.1 Global Vaccines Administered Orally Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Vaccines Administered Orally Revenue by Region (2019-2024)
2.2.3 Global Vaccines Administered Orally Revenue by Region (2025-2030)
2.2.4 Global Vaccines Administered Orally Revenue Market Share by Region (2019-2030)
2.3 Global Vaccines Administered Orally Sales Estimates and Forecasts 2019-2030
2.4 Global Vaccines Administered Orally Sales by Region
2.4.1 Global Vaccines Administered Orally Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Vaccines Administered Orally Sales by Region (2019-2024)
2.4.3 Global Vaccines Administered Orally Sales by Region (2025-2030)
2.4.4 Global Vaccines Administered Orally Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vaccines Administered Orally Sales by Manufacturers
3.1.1 Global Vaccines Administered Orally Sales by Manufacturers (2019-2024)
3.1.2 Global Vaccines Administered Orally Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines Administered Orally in 2023
3.2 Global Vaccines Administered Orally Revenue by Manufacturers
3.2.1 Global Vaccines Administered Orally Revenue by Manufacturers (2019-2024)
3.2.2 Global Vaccines Administered Orally Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vaccines Administered Orally Revenue in 2023
3.3 Global Key Players of Vaccines Administered Orally, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Vaccines Administered Orally Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vaccines Administered Orally, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vaccines Administered Orally, Product Offered and Application
3.8 Global Key Manufacturers of Vaccines Administered Orally, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccines Administered Orally Sales by Type
4.1.1 Global Vaccines Administered Orally Historical Sales by Type (2019-2024)
4.1.2 Global Vaccines Administered Orally Forecasted Sales by Type (2025-2030)
4.1.3 Global Vaccines Administered Orally Sales Market Share by Type (2019-2030)
4.2 Global Vaccines Administered Orally Revenue by Type
4.2.1 Global Vaccines Administered Orally Historical Revenue by Type (2019-2024)
4.2.2 Global Vaccines Administered Orally Forecasted Revenue by Type (2025-2030)
4.2.3 Global Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
4.3 Global Vaccines Administered Orally Price by Type
4.3.1 Global Vaccines Administered Orally Price by Type (2019-2024)
4.3.2 Global Vaccines Administered Orally Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Vaccines Administered Orally Sales by Application
5.1.1 Global Vaccines Administered Orally Historical Sales by Application (2019-2024)
5.1.2 Global Vaccines Administered Orally Forecasted Sales by Application (2025-2030)
5.1.3 Global Vaccines Administered Orally Sales Market Share by Application (2019-2030)
5.2 Global Vaccines Administered Orally Revenue by Application
5.2.1 Global Vaccines Administered Orally Historical Revenue by Application (2019-2024)
5.2.2 Global Vaccines Administered Orally Forecasted Revenue by Application (2025-2030)
5.2.3 Global Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
5.3 Global Vaccines Administered Orally Price by Application
5.3.1 Global Vaccines Administered Orally Price by Application (2019-2024)
5.3.2 Global Vaccines Administered Orally Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Vaccines Administered Orally Market Size by Type
6.1.1 US & Canada Vaccines Administered Orally Sales by Type (2019-2030)
6.1.2 US & Canada Vaccines Administered Orally Revenue by Type (2019-2030)
6.2 US & Canada Vaccines Administered Orally Market Size by Application
6.2.1 US & Canada Vaccines Administered Orally Sales by Application (2019-2030)
6.2.2 US & Canada Vaccines Administered Orally Revenue by Application (2019-2030)
6.3 US & Canada Vaccines Administered Orally Market Size by Country
6.3.1 US & Canada Vaccines Administered Orally Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Vaccines Administered Orally Sales by Country (2019-2030)
6.3.3 US & Canada Vaccines Administered Orally Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vaccines Administered Orally Market Size by Type
7.1.1 Europe Vaccines Administered Orally Sales by Type (2019-2030)
7.1.2 Europe Vaccines Administered Orally Revenue by Type (2019-2030)
7.2 Europe Vaccines Administered Orally Market Size by Application
7.2.1 Europe Vaccines Administered Orally Sales by Application (2019-2030)
7.2.2 Europe Vaccines Administered Orally Revenue by Application (2019-2030)
7.3 Europe Vaccines Administered Orally Market Size by Country
7.3.1 Europe Vaccines Administered Orally Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Vaccines Administered Orally Sales by Country (2019-2030)
7.3.3 Europe Vaccines Administered Orally Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vaccines Administered Orally Market Size
8.1.1 China Vaccines Administered Orally Sales (2019-2030)
8.1.2 China Vaccines Administered Orally Revenue (2019-2030)
8.2 China Vaccines Administered Orally Market Size by Application
8.2.1 China Vaccines Administered Orally Sales by Application (2019-2030)
8.2.2 China Vaccines Administered Orally Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Vaccines Administered Orally Market Size by Type
9.1.1 Asia Vaccines Administered Orally Sales by Type (2019-2030)
9.1.2 Asia Vaccines Administered Orally Revenue by Type (2019-2030)
9.2 Asia Vaccines Administered Orally Market Size by Application
9.2.1 Asia Vaccines Administered Orally Sales by Application (2019-2030)
9.2.2 Asia Vaccines Administered Orally Revenue by Application (2019-2030)
9.3 Asia Vaccines Administered Orally Sales by Region
9.3.1 Asia Vaccines Administered Orally Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Vaccines Administered Orally Revenue by Region (2019-2030)
9.3.3 Asia Vaccines Administered Orally Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vaccines Administered Orally Market Size by Type
10.1.1 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Vaccines Administered Orally Market Size by Application
10.2.1 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country
10.3.1 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Company Information
11.4.2 Lanzhou Institute Overview
11.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Company Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Company Information
11.6.2 Valneva Overview
11.6.3 Valneva Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Company Information
11.7.2 Shanghai United Cell Overview
11.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Company Information
11.8.2 Bibcol Overview
11.8.3 Bibcol Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Company Information
11.9.2 PaxVax Overview
11.9.3 PaxVax Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Company Information
11.10.2 Vabiotech Overview
11.10.3 Vabiotech Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Company Information
11.11.2 Tiantan Biological Overview
11.11.3 Tiantan Biological Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Company Information
11.12.2 EuBiologics Overview
11.12.3 EuBiologics Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Company Information
11.13.2 Panacea Biotec Ltd Overview
11.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Company Information
11.14.2 Bio-Med Overview
11.14.3 Bio-Med Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Company Information
11.15.2 Halfkin Bio-Pharmaceuticals Overview
11.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccines Administered Orally Industry Chain Analysis
12.2 Vaccines Administered Orally Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccines Administered Orally Production Mode & Process
12.4 Vaccines Administered Orally Sales and Marketing
12.4.1 Vaccines Administered Orally Sales Channels
12.4.2 Vaccines Administered Orally Distributors
12.5 Vaccines Administered Orally Customers
13 Market Dynamics
13.1 Vaccines Administered Orally Industry Trends
13.2 Vaccines Administered Orally Market Drivers
13.3 Vaccines Administered Orally Market Challenges
13.4 Vaccines Administered Orally Market Restraints
14 Key Findings in The Global Vaccines Administered Orally Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Vaccines Administered Orally Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Administered Orally Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Human
1.2.3 Animal
1.3 Market by Application
1.3.1 Global Vaccines Administered Orally Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vaccines Administered Orally Sales Estimates and Forecasts 2019-2030
2.2 Global Vaccines Administered Orally Revenue by Region
2.2.1 Global Vaccines Administered Orally Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Vaccines Administered Orally Revenue by Region (2019-2024)
2.2.3 Global Vaccines Administered Orally Revenue by Region (2025-2030)
2.2.4 Global Vaccines Administered Orally Revenue Market Share by Region (2019-2030)
2.3 Global Vaccines Administered Orally Sales Estimates and Forecasts 2019-2030
2.4 Global Vaccines Administered Orally Sales by Region
2.4.1 Global Vaccines Administered Orally Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Vaccines Administered Orally Sales by Region (2019-2024)
2.4.3 Global Vaccines Administered Orally Sales by Region (2025-2030)
2.4.4 Global Vaccines Administered Orally Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vaccines Administered Orally Sales by Manufacturers
3.1.1 Global Vaccines Administered Orally Sales by Manufacturers (2019-2024)
3.1.2 Global Vaccines Administered Orally Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines Administered Orally in 2023
3.2 Global Vaccines Administered Orally Revenue by Manufacturers
3.2.1 Global Vaccines Administered Orally Revenue by Manufacturers (2019-2024)
3.2.2 Global Vaccines Administered Orally Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vaccines Administered Orally Revenue in 2023
3.3 Global Key Players of Vaccines Administered Orally, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Vaccines Administered Orally Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vaccines Administered Orally, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vaccines Administered Orally, Product Offered and Application
3.8 Global Key Manufacturers of Vaccines Administered Orally, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccines Administered Orally Sales by Type
4.1.1 Global Vaccines Administered Orally Historical Sales by Type (2019-2024)
4.1.2 Global Vaccines Administered Orally Forecasted Sales by Type (2025-2030)
4.1.3 Global Vaccines Administered Orally Sales Market Share by Type (2019-2030)
4.2 Global Vaccines Administered Orally Revenue by Type
4.2.1 Global Vaccines Administered Orally Historical Revenue by Type (2019-2024)
4.2.2 Global Vaccines Administered Orally Forecasted Revenue by Type (2025-2030)
4.2.3 Global Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
4.3 Global Vaccines Administered Orally Price by Type
4.3.1 Global Vaccines Administered Orally Price by Type (2019-2024)
4.3.2 Global Vaccines Administered Orally Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Vaccines Administered Orally Sales by Application
5.1.1 Global Vaccines Administered Orally Historical Sales by Application (2019-2024)
5.1.2 Global Vaccines Administered Orally Forecasted Sales by Application (2025-2030)
5.1.3 Global Vaccines Administered Orally Sales Market Share by Application (2019-2030)
5.2 Global Vaccines Administered Orally Revenue by Application
5.2.1 Global Vaccines Administered Orally Historical Revenue by Application (2019-2024)
5.2.2 Global Vaccines Administered Orally Forecasted Revenue by Application (2025-2030)
5.2.3 Global Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
5.3 Global Vaccines Administered Orally Price by Application
5.3.1 Global Vaccines Administered Orally Price by Application (2019-2024)
5.3.2 Global Vaccines Administered Orally Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Vaccines Administered Orally Market Size by Type
6.1.1 US & Canada Vaccines Administered Orally Sales by Type (2019-2030)
6.1.2 US & Canada Vaccines Administered Orally Revenue by Type (2019-2030)
6.2 US & Canada Vaccines Administered Orally Market Size by Application
6.2.1 US & Canada Vaccines Administered Orally Sales by Application (2019-2030)
6.2.2 US & Canada Vaccines Administered Orally Revenue by Application (2019-2030)
6.3 US & Canada Vaccines Administered Orally Market Size by Country
6.3.1 US & Canada Vaccines Administered Orally Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Vaccines Administered Orally Sales by Country (2019-2030)
6.3.3 US & Canada Vaccines Administered Orally Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vaccines Administered Orally Market Size by Type
7.1.1 Europe Vaccines Administered Orally Sales by Type (2019-2030)
7.1.2 Europe Vaccines Administered Orally Revenue by Type (2019-2030)
7.2 Europe Vaccines Administered Orally Market Size by Application
7.2.1 Europe Vaccines Administered Orally Sales by Application (2019-2030)
7.2.2 Europe Vaccines Administered Orally Revenue by Application (2019-2030)
7.3 Europe Vaccines Administered Orally Market Size by Country
7.3.1 Europe Vaccines Administered Orally Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Vaccines Administered Orally Sales by Country (2019-2030)
7.3.3 Europe Vaccines Administered Orally Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vaccines Administered Orally Market Size
8.1.1 China Vaccines Administered Orally Sales (2019-2030)
8.1.2 China Vaccines Administered Orally Revenue (2019-2030)
8.2 China Vaccines Administered Orally Market Size by Application
8.2.1 China Vaccines Administered Orally Sales by Application (2019-2030)
8.2.2 China Vaccines Administered Orally Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Vaccines Administered Orally Market Size by Type
9.1.1 Asia Vaccines Administered Orally Sales by Type (2019-2030)
9.1.2 Asia Vaccines Administered Orally Revenue by Type (2019-2030)
9.2 Asia Vaccines Administered Orally Market Size by Application
9.2.1 Asia Vaccines Administered Orally Sales by Application (2019-2030)
9.2.2 Asia Vaccines Administered Orally Revenue by Application (2019-2030)
9.3 Asia Vaccines Administered Orally Sales by Region
9.3.1 Asia Vaccines Administered Orally Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Vaccines Administered Orally Revenue by Region (2019-2030)
9.3.3 Asia Vaccines Administered Orally Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vaccines Administered Orally Market Size by Type
10.1.1 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Vaccines Administered Orally Market Size by Application
10.2.1 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country
10.3.1 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Company Information
11.4.2 Lanzhou Institute Overview
11.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Company Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Company Information
11.6.2 Valneva Overview
11.6.3 Valneva Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Company Information
11.7.2 Shanghai United Cell Overview
11.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Company Information
11.8.2 Bibcol Overview
11.8.3 Bibcol Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Company Information
11.9.2 PaxVax Overview
11.9.3 PaxVax Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Company Information
11.10.2 Vabiotech Overview
11.10.3 Vabiotech Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Company Information
11.11.2 Tiantan Biological Overview
11.11.3 Tiantan Biological Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Company Information
11.12.2 EuBiologics Overview
11.12.3 EuBiologics Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Company Information
11.13.2 Panacea Biotec Ltd Overview
11.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Company Information
11.14.2 Bio-Med Overview
11.14.3 Bio-Med Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Company Information
11.15.2 Halfkin Bio-Pharmaceuticals Overview
11.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccines Administered Orally Industry Chain Analysis
12.2 Vaccines Administered Orally Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccines Administered Orally Production Mode & Process
12.4 Vaccines Administered Orally Sales and Marketing
12.4.1 Vaccines Administered Orally Sales Channels
12.4.2 Vaccines Administered Orally Distributors
12.5 Vaccines Administered Orally Customers
13 Market Dynamics
13.1 Vaccines Administered Orally Industry Trends
13.2 Vaccines Administered Orally Market Drivers
13.3 Vaccines Administered Orally Market Challenges
13.4 Vaccines Administered Orally Market Restraints
14 Key Findings in The Global Vaccines Administered Orally Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vaccines Administered Orally Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Animal
Table 4. Global Vaccines Administered Orally Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Vaccines Administered Orally Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Vaccines Administered Orally Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Vaccines Administered Orally Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
Table 9. Global Vaccines Administered Orally Revenue Market Share by Region (2025-2030)
Table 10. Global Vaccines Administered Orally Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Vaccines Administered Orally Sales by Region (2019-2024) & (K Units)
Table 12. Global Vaccines Administered Orally Sales by Region (2025-2030) & (K Units)
Table 13. Global Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Table 14. Global Vaccines Administered Orally Sales Market Share by Region (2025-2030)
Table 15. Global Vaccines Administered Orally Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Vaccines Administered Orally Sales Share by Manufacturers (2019-2024)
Table 17. Global Vaccines Administered Orally Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Vaccines Administered Orally Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Vaccines Administered Orally, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Vaccines Administered Orally Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Vaccines Administered Orally Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vaccines Administered Orally by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines Administered Orally as of 2023)
Table 23. Global Key Manufacturers of Vaccines Administered Orally, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vaccines Administered Orally, Product Offered and Application
Table 25. Global Key Manufacturers of Vaccines Administered Orally, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 28. Global Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 29. Global Vaccines Administered Orally Sales Share by Type (2019-2024)
Table 30. Global Vaccines Administered Orally Sales Share by Type (2025-2030)
Table 31. Global Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Vaccines Administered Orally Revenue Share by Type (2019-2024)
Table 34. Global Vaccines Administered Orally Revenue Share by Type (2025-2030)
Table 35. Vaccines Administered Orally Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Vaccines Administered Orally Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 38. Global Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 39. Global Vaccines Administered Orally Sales Share by Application (2019-2024)
Table 40. Global Vaccines Administered Orally Sales Share by Application (2025-2030)
Table 41. Global Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Vaccines Administered Orally Revenue Share by Application (2019-2024)
Table 44. Global Vaccines Administered Orally Revenue Share by Application (2025-2030)
Table 45. Vaccines Administered Orally Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Vaccines Administered Orally Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Vaccines Administered Orally Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Vaccines Administered Orally Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Vaccines Administered Orally Sales by Country (2025-2030) & (K Units)
Table 60. Europe Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 61. Europe Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 62. Europe Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 65. Europe Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 66. Europe Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Vaccines Administered Orally Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Vaccines Administered Orally Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 72. Europe Vaccines Administered Orally Sales by Country (2025-2030) & (K Units)
Table 73. China Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 74. China Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 75. China Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 78. China Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 79. China Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 82. Asia Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 83. Asia Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 86. Asia Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 87. Asia Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Vaccines Administered Orally Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Vaccines Administered Orally Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Vaccines Administered Orally Sales by Region (2019-2024) & (K Units)
Table 93. Asia Vaccines Administered Orally Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country (2025-2030) & (K Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Lanzhou Institute Company Information
Table 123. Lanzhou Institute Description and Major Businesses
Table 124. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lanzhou Institute Recent Developments
Table 127. Serum Institute Company Information
Table 128. Serum Institute Description and Major Businesses
Table 129. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Serum Institute Recent Developments
Table 132. Valneva Company Information
Table 133. Valneva Description and Major Businesses
Table 134. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Valneva Recent Developments
Table 137. Shanghai United Cell Company Information
Table 138. Shanghai United Cell Description and Major Businesses
Table 139. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shanghai United Cell Recent Developments
Table 142. Bibcol Company Information
Table 143. Bibcol Description and Major Businesses
Table 144. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bibcol Recent Developments
Table 147. PaxVax Company Information
Table 148. PaxVax Description and Major Businesses
Table 149. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PaxVax Recent Developments
Table 152. Vabiotech Company Information
Table 153. Vabiotech Description and Major Businesses
Table 154. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Vabiotech Recent Developments
Table 157. Tiantan Biological Company Information
Table 158. Tiantan Biological Description and Major Businesses
Table 159. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Tiantan Biological Recent Developments
Table 162. EuBiologics Company Information
Table 163. EuBiologics Description and Major Businesses
Table 164. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. EuBiologics Recent Developments
Table 167. Panacea Biotec Ltd Company Information
Table 168. Panacea Biotec Ltd Description and Major Businesses
Table 169. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 170. Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Panacea Biotec Ltd Recent Developments
Table 172. Bio-Med Company Information
Table 173. Bio-Med Description and Major Businesses
Table 174. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 175. Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Bio-Med Recent Developments
Table 177. Halfkin Bio-Pharmaceuticals Company Information
Table 178. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 179. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 180. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Halfkin Bio-Pharmaceuticals Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Vaccines Administered Orally Distributors List
Table 185. Vaccines Administered Orally Customers List
Table 186. Vaccines Administered Orally Market Trends
Table 187. Vaccines Administered Orally Market Drivers
Table 188. Vaccines Administered Orally Market Challenges
Table 189. Vaccines Administered Orally Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Administered Orally Product Picture
Figure 2. Global Vaccines Administered Orally Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Vaccines Administered Orally Market Share by Type in 2023 & 2030
Figure 4. Human Product Picture
Figure 5. Animal Product Picture
Figure 6. Global Vaccines Administered Orally Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Vaccines Administered Orally Market Share by Application in 2023 & 2030
Figure 8. Public
Figure 9. Private
Figure 10. Vaccines Administered Orally Report Years Considered
Figure 11. Global Vaccines Administered Orally Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Vaccines Administered Orally Revenue 2019-2030 (US$ Million)
Figure 13. Global Vaccines Administered Orally Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Vaccines Administered Orally Revenue Market Share by Region (2019-2030)
Figure 15. Global Vaccines Administered Orally Sales 2019-2030 ((K Units)
Figure 16. Global Vaccines Administered Orally Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 18. US & Canada Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 20. Europe Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 22. China Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 24. Asia (excluding China) Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 26. Middle East, Africa and Latin America Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Vaccines Administered Orally Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Vaccines Administered Orally in the World: Market Share by Vaccines Administered Orally Revenue in 2023
Figure 29. Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 31. Global Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 32. Global Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 33. Global Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Vaccines Administered Orally Revenue Share by Country (2019-2030)
Figure 39. US & Canada Vaccines Administered Orally Sales Share by Country (2019-2030)
Figure 40. U.S. Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 43. Europe Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 44. Europe Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 45. Europe Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 46. Europe Vaccines Administered Orally Revenue Share by Country (2019-2030)
Figure 47. Europe Vaccines Administered Orally Sales Share by Country (2019-2030)
Figure 48. Germany Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 49. France Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 53. China Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 54. China Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 55. China Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 56. China Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 57. Asia Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 58. Asia Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 59. Asia Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 60. Asia Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 61. Asia Vaccines Administered Orally Revenue Share by Region (2019-2030)
Figure 62. Asia Vaccines Administered Orally Sales Share by Region (2019-2030)
Figure 63. Japan Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 67. India Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Vaccines Administered Orally Sales Share by Country (2019-2030)
Figure 74. Brazil Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 79. Vaccines Administered Orally Value Chain
Figure 80. Vaccines Administered Orally Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Table 1. Global Vaccines Administered Orally Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Animal
Table 4. Global Vaccines Administered Orally Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Vaccines Administered Orally Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Vaccines Administered Orally Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Vaccines Administered Orally Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
Table 9. Global Vaccines Administered Orally Revenue Market Share by Region (2025-2030)
Table 10. Global Vaccines Administered Orally Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Vaccines Administered Orally Sales by Region (2019-2024) & (K Units)
Table 12. Global Vaccines Administered Orally Sales by Region (2025-2030) & (K Units)
Table 13. Global Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Table 14. Global Vaccines Administered Orally Sales Market Share by Region (2025-2030)
Table 15. Global Vaccines Administered Orally Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Vaccines Administered Orally Sales Share by Manufacturers (2019-2024)
Table 17. Global Vaccines Administered Orally Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Vaccines Administered Orally Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Vaccines Administered Orally, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Vaccines Administered Orally Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Vaccines Administered Orally Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Vaccines Administered Orally by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines Administered Orally as of 2023)
Table 23. Global Key Manufacturers of Vaccines Administered Orally, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Vaccines Administered Orally, Product Offered and Application
Table 25. Global Key Manufacturers of Vaccines Administered Orally, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 28. Global Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 29. Global Vaccines Administered Orally Sales Share by Type (2019-2024)
Table 30. Global Vaccines Administered Orally Sales Share by Type (2025-2030)
Table 31. Global Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Vaccines Administered Orally Revenue Share by Type (2019-2024)
Table 34. Global Vaccines Administered Orally Revenue Share by Type (2025-2030)
Table 35. Vaccines Administered Orally Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Vaccines Administered Orally Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 38. Global Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 39. Global Vaccines Administered Orally Sales Share by Application (2019-2024)
Table 40. Global Vaccines Administered Orally Sales Share by Application (2025-2030)
Table 41. Global Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Vaccines Administered Orally Revenue Share by Application (2019-2024)
Table 44. Global Vaccines Administered Orally Revenue Share by Application (2025-2030)
Table 45. Vaccines Administered Orally Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Vaccines Administered Orally Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Vaccines Administered Orally Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Vaccines Administered Orally Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Vaccines Administered Orally Sales by Country (2025-2030) & (K Units)
Table 60. Europe Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 61. Europe Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 62. Europe Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 65. Europe Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 66. Europe Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Vaccines Administered Orally Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Vaccines Administered Orally Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 72. Europe Vaccines Administered Orally Sales by Country (2025-2030) & (K Units)
Table 73. China Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 74. China Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 75. China Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 78. China Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 79. China Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 82. Asia Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 83. Asia Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 86. Asia Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 87. Asia Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Vaccines Administered Orally Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Vaccines Administered Orally Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Vaccines Administered Orally Sales by Region (2019-2024) & (K Units)
Table 93. Asia Vaccines Administered Orally Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Vaccines Administered Orally Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Vaccines Administered Orally Sales by Country (2025-2030) & (K Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Lanzhou Institute Company Information
Table 123. Lanzhou Institute Description and Major Businesses
Table 124. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lanzhou Institute Recent Developments
Table 127. Serum Institute Company Information
Table 128. Serum Institute Description and Major Businesses
Table 129. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Serum Institute Recent Developments
Table 132. Valneva Company Information
Table 133. Valneva Description and Major Businesses
Table 134. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Valneva Recent Developments
Table 137. Shanghai United Cell Company Information
Table 138. Shanghai United Cell Description and Major Businesses
Table 139. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shanghai United Cell Recent Developments
Table 142. Bibcol Company Information
Table 143. Bibcol Description and Major Businesses
Table 144. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bibcol Recent Developments
Table 147. PaxVax Company Information
Table 148. PaxVax Description and Major Businesses
Table 149. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PaxVax Recent Developments
Table 152. Vabiotech Company Information
Table 153. Vabiotech Description and Major Businesses
Table 154. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Vabiotech Recent Developments
Table 157. Tiantan Biological Company Information
Table 158. Tiantan Biological Description and Major Businesses
Table 159. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Tiantan Biological Recent Developments
Table 162. EuBiologics Company Information
Table 163. EuBiologics Description and Major Businesses
Table 164. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. EuBiologics Recent Developments
Table 167. Panacea Biotec Ltd Company Information
Table 168. Panacea Biotec Ltd Description and Major Businesses
Table 169. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 170. Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Panacea Biotec Ltd Recent Developments
Table 172. Bio-Med Company Information
Table 173. Bio-Med Description and Major Businesses
Table 174. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 175. Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Bio-Med Recent Developments
Table 177. Halfkin Bio-Pharmaceuticals Company Information
Table 178. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 179. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 180. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Halfkin Bio-Pharmaceuticals Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Vaccines Administered Orally Distributors List
Table 185. Vaccines Administered Orally Customers List
Table 186. Vaccines Administered Orally Market Trends
Table 187. Vaccines Administered Orally Market Drivers
Table 188. Vaccines Administered Orally Market Challenges
Table 189. Vaccines Administered Orally Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Administered Orally Product Picture
Figure 2. Global Vaccines Administered Orally Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Vaccines Administered Orally Market Share by Type in 2023 & 2030
Figure 4. Human Product Picture
Figure 5. Animal Product Picture
Figure 6. Global Vaccines Administered Orally Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Vaccines Administered Orally Market Share by Application in 2023 & 2030
Figure 8. Public
Figure 9. Private
Figure 10. Vaccines Administered Orally Report Years Considered
Figure 11. Global Vaccines Administered Orally Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Vaccines Administered Orally Revenue 2019-2030 (US$ Million)
Figure 13. Global Vaccines Administered Orally Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Vaccines Administered Orally Revenue Market Share by Region (2019-2030)
Figure 15. Global Vaccines Administered Orally Sales 2019-2030 ((K Units)
Figure 16. Global Vaccines Administered Orally Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 18. US & Canada Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 20. Europe Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 22. China Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 24. Asia (excluding China) Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Vaccines Administered Orally Sales YoY (2019-2030) & (K Units)
Figure 26. Middle East, Africa and Latin America Vaccines Administered Orally Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Vaccines Administered Orally Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Vaccines Administered Orally in the World: Market Share by Vaccines Administered Orally Revenue in 2023
Figure 29. Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 31. Global Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 32. Global Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 33. Global Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Vaccines Administered Orally Revenue Share by Country (2019-2030)
Figure 39. US & Canada Vaccines Administered Orally Sales Share by Country (2019-2030)
Figure 40. U.S. Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 43. Europe Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 44. Europe Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 45. Europe Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 46. Europe Vaccines Administered Orally Revenue Share by Country (2019-2030)
Figure 47. Europe Vaccines Administered Orally Sales Share by Country (2019-2030)
Figure 48. Germany Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 49. France Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 53. China Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 54. China Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 55. China Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 56. China Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 57. Asia Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 58. Asia Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 59. Asia Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 60. Asia Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 61. Asia Vaccines Administered Orally Revenue Share by Region (2019-2030)
Figure 62. Asia Vaccines Administered Orally Sales Share by Region (2019-2030)
Figure 63. Japan Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 67. India Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Vaccines Administered Orally Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Vaccines Administered Orally Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Vaccines Administered Orally Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Vaccines Administered Orally Sales Share by Country (2019-2030)
Figure 74. Brazil Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Vaccines Administered Orally Revenue (2019-2030) & (US$ Million)
Figure 79. Vaccines Administered Orally Value Chain
Figure 80. Vaccines Administered Orally Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232